SALT LAKE CITY, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and distinct mechanisms of action, today announced that Robert Lollini, President and Chief Executive Officer, will be presenting at the 2011 Rodman and Renshaw Annual Healthcare Conference being held September 11-13, at the Waldorf=Astoria Hotel in New York City. Mr. Lollini will be available to participate in one-on-one meetings with investors registered to attend the conference.
